✦ LIBER ✦
A pilot pharmacokinetic and immunoscintigraphic study with the technetium-99m-labeled monoclonal antibody BC-1 directed against oncofetal fibronectin in patients with brain tumors
✍ Scribed by Giuliano Mariani; Arben Lasku; Antonio Pau; Giuseppe Villa; Cinzia Motta; Giuseppina Calcagno; Gioconda Z. Taddei; Patrizia Castellani; Kostas Syrigos; Alessandra Dorcaratto; Agamennon A. Epenetos; Luciano Zardi; Giuseppe A. Viale
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 338 KB
- Volume
- 80
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
✦ Synopsis
tumor targeting potential in vivo of radiolabeled BC-1, an immunoglobulin (Ig)G 1 monoclonal antibody (MoAb) that recognizes the human fibronectin isoform (B / ) containing